

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mesoderm development (GO:0007498) | 8.97897961 |
| 2 | mesenchyme development (GO:0060485) | 8.10627510 |
| 3 | gonadal mesoderm development (GO:0007506) | 60.5879449 |
| 4 | N-acetylneuraminate metabolic process (GO:0006054) | 5.90339137 |
| 5 | sex differentiation (GO:0007548) | 5.30461257 |
| 6 | nucleosome assembly (GO:0006334) | 5.08455893 |
| 7 | protein-DNA complex assembly (GO:0065004) | 4.26237208 |
| 8 | nucleosome organization (GO:0034728) | 4.04375027 |
| 9 | complement activation, classical pathway (GO:0006958) | 4.02094483 |
| 10 | protein-DNA complex subunit organization (GO:0071824) | 3.49098188 |
| 11 | complement activation (GO:0006956) | 3.04635268 |
| 12 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.02518793 |
| 13 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.87600557 |
| 14 | regulation of activation of Janus kinase activity (GO:0010533) | 2.86677379 |
| 15 | apoptotic cell clearance (GO:0043277) | 2.85710505 |
| 16 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.83134165 |
| 17 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.83134165 |
| 18 | positive regulation of respiratory burst (GO:0060267) | 2.53542117 |
| 19 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.46272006 |
| 20 | COPI coating of Golgi vesicle (GO:0048205) | 2.33271634 |
| 21 | Golgi transport vesicle coating (GO:0048200) | 2.33271634 |
| 22 | amyloid precursor protein catabolic process (GO:0042987) | 2.33232105 |
| 23 | ribosomal small subunit biogenesis (GO:0042274) | 2.33109174 |
| 24 | sialylation (GO:0097503) | 2.31010748 |
| 25 | humoral immune response (GO:0006959) | 2.22341266 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.16627689 |
| 27 | protein activation cascade (GO:0072376) | 2.15305314 |
| 28 | amyloid precursor protein metabolic process (GO:0042982) | 2.14485093 |
| 29 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.05314256 |
| 30 | oligosaccharide catabolic process (GO:0009313) | 2.02219493 |
| 31 | positive regulation of viral genome replication (GO:0045070) | 2.00864287 |
| 32 | negative thymic T cell selection (GO:0045060) | 2.00793099 |
| 33 | cellular response to interleukin-6 (GO:0071354) | 1.99117386 |
| 34 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 1.91693129 |
| 35 | ganglioside metabolic process (GO:0001573) | 1.88072298 |
| 36 | organ or tissue specific immune response (GO:0002251) | 1.87561872 |
| 37 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 1.87409429 |
| 38 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 1.86699968 |
| 39 | Fc-gamma receptor signaling pathway (GO:0038094) | 1.86699968 |
| 40 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 1.86699968 |
| 41 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 1.84476404 |
| 42 | negative regulation of Notch signaling pathway (GO:0045746) | 1.83069163 |
| 43 | negative T cell selection (GO:0043383) | 1.80257168 |
| 44 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 1.79464282 |
| 45 | neutrophil mediated immunity (GO:0002446) | 1.78949194 |
| 46 | positive regulation of isotype switching (GO:0045830) | 1.78542723 |
| 47 | sodium ion homeostasis (GO:0055078) | 1.77732742 |
| 48 | cellular sodium ion homeostasis (GO:0006883) | 1.74947601 |
| 49 | protein K63-linked deubiquitination (GO:0070536) | 1.73800359 |
| 50 | protein N-linked glycosylation via asparagine (GO:0018279) | 1.73051095 |
| 51 | peptidyl-asparagine modification (GO:0018196) | 1.71557698 |
| 52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 1.70705423 |
| 53 | protein localization to endoplasmic reticulum (GO:0070972) | 1.69648366 |
| 54 | regulation of respiratory burst (GO:0060263) | 1.69015706 |
| 55 | ER overload response (GO:0006983) | 1.67995358 |
| 56 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 1.67528561 |
| 57 | reproductive structure development (GO:0048608) | 1.65698021 |
| 58 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 1.65438464 |
| 59 | protein targeting to ER (GO:0045047) | 1.64928942 |
| 60 | COPII vesicle coating (GO:0048208) | 1.64641001 |
| 61 | cotranslational protein targeting to membrane (GO:0006613) | 1.63512824 |
| 62 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 1.62937791 |
| 63 | myeloid cell homeostasis (GO:0002262) | 1.62115073 |
| 64 | autophagic vacuole fusion (GO:0000046) | 1.61947826 |
| 65 | viral transcription (GO:0019083) | 1.61225748 |
| 66 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 1.60038517 |
| 67 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 1.58905322 |
| 68 | protein N-linked glycosylation (GO:0006487) | 1.58827498 |
| 69 | response to interleukin-6 (GO:0070741) | 1.58722885 |
| 70 | Fc-epsilon receptor signaling pathway (GO:0038095) | 1.58678731 |
| 71 | cytokine biosynthetic process (GO:0042089) | 1.57778081 |
| 72 | protein K48-linked deubiquitination (GO:0071108) | 1.57323229 |
| 73 | amino sugar metabolic process (GO:0006040) | 1.56851749 |
| 74 | modulation by virus of host process (GO:0019054) | 1.56406572 |
| 75 | antibacterial humoral response (GO:0019731) | 1.56372783 |
| 76 | translational termination (GO:0006415) | 1.54353127 |
| 77 | negative regulation of interleukin-8 production (GO:0032717) | 1.54307902 |
| 78 | antimicrobial humoral response (GO:0019730) | 1.53660591 |
| 79 | amino sugar catabolic process (GO:0046348) | 1.53408722 |
| 80 | regulation of nuclease activity (GO:0032069) | 1.52927593 |
| 81 | monocyte chemotaxis (GO:0002548) | 1.52860910 |
| 82 | membrane protein intracellular domain proteolysis (GO:0031293) | 1.52675551 |
| 83 | positive regulation of DNA recombination (GO:0045911) | 1.52499597 |
| 84 | endoplasmic reticulum unfolded protein response (GO:0030968) | 1.51647298 |
| 85 | glycosphingolipid catabolic process (GO:0046479) | 1.49986830 |
| 86 | regulation of mitochondrial membrane permeability (GO:0046902) | 1.49432582 |
| 87 | response to endoplasmic reticulum stress (GO:0034976) | 1.48544147 |
| 88 | spermatogenesis (GO:0007283) | 1.47562150 |
| 89 | signal peptide processing (GO:0006465) | 1.47271685 |
| 90 | male gamete generation (GO:0048232) | 1.46713291 |
| 91 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 1.46485228 |
| 92 | mitochondrial calcium ion transport (GO:0006851) | 1.45384583 |
| 93 | germinal center formation (GO:0002467) | 1.45201786 |
| 94 | translational elongation (GO:0006414) | 1.44559896 |
| 95 | cellular response to unfolded protein (GO:0034620) | 1.44426658 |
| 96 | regulation of cellular extravasation (GO:0002691) | 1.44221878 |
| 97 | regulation of defense response to virus by virus (GO:0050690) | 1.42932358 |
| 98 | cellular response to virus (GO:0098586) | 1.42849718 |
| 99 | positive regulation of nuclease activity (GO:0032075) | 1.42399050 |
| 100 | regulation of membrane permeability (GO:0090559) | 1.42307185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.66230780 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.54340472 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.42220260 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.01361381 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.77440773 |
| 6 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.77246176 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.67944020 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.59868630 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.49127873 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.38171998 |
| 11 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.37854648 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.20641215 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.07667812 |
| 14 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 2.04464260 |
| 15 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.02776679 |
| 16 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.01777456 |
| 17 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.93521836 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.92519344 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.92226476 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.91893730 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.83698494 |
| 22 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82224038 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.77017670 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74079704 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.71623918 |
| 26 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.64030846 |
| 27 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.62412524 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61502060 |
| 29 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.60862845 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59287269 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58405024 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.58005208 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57539572 |
| 34 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.57508811 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52990778 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52354437 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52295663 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51389606 |
| 39 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.48296113 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.46770454 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46621566 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46533442 |
| 43 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.46528062 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45746659 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43361611 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42827617 |
| 47 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.42735283 |
| 48 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.42656324 |
| 49 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.41868420 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.41165016 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41047032 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40758201 |
| 53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39458352 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.38397130 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38259822 |
| 56 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38184030 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36963639 |
| 58 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.35893296 |
| 59 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35783664 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35377083 |
| 61 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.34780812 |
| 62 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.32527748 |
| 63 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.32494881 |
| 64 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.29295214 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28750037 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.26871561 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.26725757 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.26417337 |
| 69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24623163 |
| 70 | MYB_26560356_Chip-Seq_TH1_Human | 1.24451524 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23184247 |
| 72 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22341692 |
| 73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.21554506 |
| 74 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20940948 |
| 75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20733643 |
| 76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17692697 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16470883 |
| 78 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15216209 |
| 79 | MAF_26560356_Chip-Seq_TH1_Human | 1.14720767 |
| 80 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.13248038 |
| 81 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12796176 |
| 82 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.12640892 |
| 83 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12459312 |
| 84 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11524276 |
| 85 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.11464917 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11267203 |
| 87 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10656475 |
| 88 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.10604586 |
| 89 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10111335 |
| 90 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.09367268 |
| 91 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08923789 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08551949 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05558212 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03028644 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02628737 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02485698 |
| 97 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00640670 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99593837 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97380966 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96677744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 9.38098172 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.98012629 |
| 3 | MP0009333_abnormal_splenocyte_physiolog | 3.60042054 |
| 4 | MP0003136_yellow_coat_color | 3.56581546 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.06969949 |
| 6 | MP0009840_abnormal_foam_cell | 2.86951709 |
| 7 | MP0005451_abnormal_body_composition | 2.72545398 |
| 8 | MP0005671_abnormal_response_to | 2.58935267 |
| 9 | MP0005171_absent_coat_pigmentation | 2.41852311 |
| 10 | MP0000685_abnormal_immune_system | 2.36264444 |
| 11 | MP0001348_abnormal_lacrimal_gland | 2.31016268 |
| 12 | MP0001663_abnormal_digestive_system | 2.20034442 |
| 13 | MP0004043_abnormal_pH_regulation | 2.02266560 |
| 14 | MP0001800_abnormal_humoral_immune | 1.97885196 |
| 15 | MP0009785_altered_susceptibility_to | 1.95474408 |
| 16 | MP0003172_abnormal_lysosome_physiology | 1.93581092 |
| 17 | MP0001835_abnormal_antigen_presentation | 1.88608916 |
| 18 | MP0003763_abnormal_thymus_physiology | 1.86274417 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.83648831 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.81691042 |
| 21 | MP0005025_abnormal_response_to | 1.72923497 |
| 22 | MP0005387_immune_system_phenotype | 1.71718094 |
| 23 | MP0001790_abnormal_immune_system | 1.71718094 |
| 24 | MP0005381_digestive/alimentary_phenotyp | 1.70250740 |
| 25 | MP0003693_abnormal_embryo_hatching | 1.57260069 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.56991923 |
| 27 | MP0002168_other_aberrant_phenotype | 1.56648685 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.50656891 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.49411109 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.42934237 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.40969091 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.40591320 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.38455848 |
| 34 | MP0002796_impaired_skin_barrier | 1.35310320 |
| 35 | MP0006082_CNS_inflammation | 1.34988522 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.33826223 |
| 37 | MP0001819_abnormal_immune_cell | 1.33177345 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.31556398 |
| 39 | MP0002723_abnormal_immune_serum | 1.29152694 |
| 40 | MP0000716_abnormal_immune_system | 1.27535662 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.27339547 |
| 42 | MP0010307_abnormal_tumor_latency | 1.26526469 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.25627665 |
| 44 | MP0003866_abnormal_defecation | 1.20138358 |
| 45 | MP0002398_abnormal_bone_marrow | 1.16650356 |
| 46 | MP0004264_abnormal_extraembryonic_tissu | 1.14600668 |
| 47 | MP0003868_abnormal_feces_composition | 1.14450404 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.14237956 |
| 49 | MP0002429_abnormal_blood_cell | 1.11904194 |
| 50 | MP0004957_abnormal_blastocyst_morpholog | 1.10519685 |
| 51 | MP0003436_decreased_susceptibility_to | 1.07328918 |
| 52 | MP0000747_muscle_weakness | 1.06314600 |
| 53 | MP0005408_hypopigmentation | 1.04169170 |
| 54 | MP0005395_other_phenotype | 0.99872702 |
| 55 | MP0002419_abnormal_innate_immunity | 0.99560657 |
| 56 | MP0002090_abnormal_vision | 0.98095013 |
| 57 | MP0009643_abnormal_urine_homeostasis | 0.96677119 |
| 58 | MP0003111_abnormal_nucleus_morphology | 0.91663781 |
| 59 | MP0002166_altered_tumor_susceptibility | 0.88539619 |
| 60 | MP0000343_altered_response_to | 0.88374622 |
| 61 | MP0002722_abnormal_immune_system | 0.86456500 |
| 62 | MP0008569_lethality_at_weaning | 0.85023583 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 0.84470776 |
| 64 | MP0001873_stomach_inflammation | 0.82976807 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 0.82148951 |
| 66 | MP0000490_abnormal_crypts_of | 0.81520523 |
| 67 | MP0001664_abnormal_digestion | 0.81299616 |
| 68 | MP0005166_decreased_susceptibility_to | 0.79094797 |
| 69 | MP0004947_skin_inflammation | 0.77382301 |
| 70 | MP0005360_urolithiasis | 0.77169615 |
| 71 | MP0002396_abnormal_hematopoietic_system | 0.77009391 |
| 72 | MP0003221_abnormal_cardiomyocyte_apopto | 0.75769108 |
| 73 | MP0001756_abnormal_urination | 0.74514684 |
| 74 | MP0000703_abnormal_thymus_morphology | 0.73430681 |
| 75 | MP0008469_abnormal_protein_level | 0.72672729 |
| 76 | MP0001851_eye_inflammation | 0.72531724 |
| 77 | MP0002693_abnormal_pancreas_physiology | 0.70840775 |
| 78 | MP0005310_abnormal_salivary_gland | 0.70538279 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69993592 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 0.69778708 |
| 81 | MP0003724_increased_susceptibility_to | 0.69512224 |
| 82 | MP0002822_catalepsy | 0.68420541 |
| 83 | MP0003091_abnormal_cell_migration | 0.67491844 |
| 84 | MP0008004_abnormal_stomach_pH | 0.67029346 |
| 85 | MP0001542_abnormal_bone_strength | 0.66315316 |
| 86 | MP0003795_abnormal_bone_structure | 0.65909434 |
| 87 | MP0001186_pigmentation_phenotype | 0.65394222 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.64026609 |
| 89 | MP0000313_abnormal_cell_death | 0.63235754 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 0.62855272 |
| 91 | MP0001661_extended_life_span | 0.61900384 |
| 92 | MP0003045_fibrosis | 0.61564443 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.61081569 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 0.60502251 |
| 95 | MP0000477_abnormal_intestine_morphology | 0.60070407 |
| 96 | MP0005670_abnormal_white_adipose | 0.59793216 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.59326682 |
| 98 | MP0002896_abnormal_bone_mineralization | 0.59280755 |
| 99 | MP0008874_decreased_physiological_sensi | 0.58722144 |
| 100 | MP0002405_respiratory_system_inflammati | 0.57703428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.18848921 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 5.08078841 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.06887008 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.99302529 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.99302529 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.99302529 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 4.68438311 |
| 8 | Decreased circulating renin level (HP:0003351) | 4.61693181 |
| 9 | Dysostosis multiplex (HP:0000943) | 4.19759641 |
| 10 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.18278917 |
| 11 | Vertebral compression fractures (HP:0002953) | 3.82020102 |
| 12 | Abnormal tarsal ossification (HP:0008369) | 3.71948748 |
| 13 | Large for gestational age (HP:0001520) | 3.57661835 |
| 14 | Ankyloglossia (HP:0010296) | 3.55982186 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.46942510 |
| 16 | Albinism (HP:0001022) | 3.34153612 |
| 17 | Tetraparesis (HP:0002273) | 3.28994477 |
| 18 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.22877126 |
| 19 | Syringomyelia (HP:0003396) | 3.19697141 |
| 20 | Spinal cord lesions (HP:0100561) | 3.19697141 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.18975533 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.18975533 |
| 23 | Patchy hypopigmentation of hair (HP:0011365) | 3.09776084 |
| 24 | Carpal bone hypoplasia (HP:0001498) | 3.08724657 |
| 25 | Ridged nail (HP:0001807) | 3.01735112 |
| 26 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.00828632 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.92699081 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 2.88299484 |
| 29 | Overlapping toe (HP:0001845) | 2.80681092 |
| 30 | Onycholysis (HP:0001806) | 2.76807560 |
| 31 | Abnormality of oral frenula (HP:0000190) | 2.73276225 |
| 32 | Urticaria (HP:0001025) | 2.66375455 |
| 33 | Thoracolumbar scoliosis (HP:0002944) | 2.60866942 |
| 34 | Villous atrophy (HP:0011473) | 2.59827309 |
| 35 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.59827309 |
| 36 | Abnormal foot bone ossification (HP:0010675) | 2.56464690 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 2.55127111 |
| 38 | Colitis (HP:0002583) | 2.53322689 |
| 39 | Hypokalemic alkalosis (HP:0001949) | 2.50862744 |
| 40 | Hyperkalemia (HP:0002153) | 2.48846038 |
| 41 | Dry hair (HP:0011359) | 2.48419056 |
| 42 | Small epiphyses (HP:0010585) | 2.46650950 |
| 43 | Abnormality of the lumbar spine (HP:0100712) | 2.45186757 |
| 44 | Erythema (HP:0010783) | 2.43839902 |
| 45 | Abnormality of incisor morphology (HP:0011063) | 2.40863076 |
| 46 | Spastic paraparesis (HP:0002313) | 2.40391445 |
| 47 | Microretrognathia (HP:0000308) | 2.40232830 |
| 48 | Long palpebral fissure (HP:0000637) | 2.35997658 |
| 49 | Deformed sella turcica (HP:0002681) | 2.31814834 |
| 50 | Abnormality of renin-angiotensin system (HP:0000847) | 2.30972791 |
| 51 | Reticulocytopenia (HP:0001896) | 2.29476573 |
| 52 | Curly hair (HP:0002212) | 2.28070083 |
| 53 | Progressive visual loss (HP:0000529) | 2.26463061 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24333921 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24333921 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24333921 |
| 57 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.23552887 |
| 58 | Chronic bronchitis (HP:0004469) | 2.22207705 |
| 59 | Exocrine pancreatic insufficiency (HP:0001738) | 2.21056864 |
| 60 | Abnormality of chloride homeostasis (HP:0011422) | 2.20338880 |
| 61 | White forelock (HP:0002211) | 2.20321140 |
| 62 | Exercise-induced myalgia (HP:0003738) | 2.18494025 |
| 63 | Thoracic kyphosis (HP:0002942) | 2.17757587 |
| 64 | Hyponatremia (HP:0002902) | 2.16543927 |
| 65 | Deep palmar crease (HP:0006191) | 2.15869866 |
| 66 | Lower limb hyperreflexia (HP:0002395) | 2.13607250 |
| 67 | Loss of speech (HP:0002371) | 2.12539535 |
| 68 | Recurrent viral infections (HP:0004429) | 2.12195579 |
| 69 | Increased IgE level (HP:0003212) | 2.11243846 |
| 70 | Hypercortisolism (HP:0001578) | 2.10559921 |
| 71 | Unilateral renal agenesis (HP:0000122) | 2.10136785 |
| 72 | Asymmetry of the thorax (HP:0001555) | 2.10118085 |
| 73 | Increased IgM level (HP:0003496) | 2.07691857 |
| 74 | Short middle phalanx of the 5th finger (HP:0004220) | 2.06789834 |
| 75 | Acute hepatic failure (HP:0006554) | 2.06475996 |
| 76 | Coarse hair (HP:0002208) | 2.05792529 |
| 77 | J-shaped sella turcica (HP:0002680) | 2.04562583 |
| 78 | Abnormal pupillary function (HP:0007686) | 2.03084738 |
| 79 | Alkalosis (HP:0001948) | 2.00815807 |
| 80 | Adrenal overactivity (HP:0002717) | 1.99496047 |
| 81 | Premature loss of primary teeth (HP:0006323) | 1.98536854 |
| 82 | Abnormal auditory evoked potentials (HP:0006958) | 1.98477331 |
| 83 | Paraparesis (HP:0002385) | 1.97348328 |
| 84 | Mucopolysacchariduria (HP:0008155) | 1.95248521 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95248521 |
| 86 | Visual hallucinations (HP:0002367) | 1.95050208 |
| 87 | Flattened epiphyses (HP:0003071) | 1.94348192 |
| 88 | Renal salt wasting (HP:0000127) | 1.93148175 |
| 89 | Hyperlipoproteinemia (HP:0010980) | 1.93117679 |
| 90 | Prolonged neonatal jaundice (HP:0006579) | 1.92987260 |
| 91 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92318227 |
| 92 | Abnormal protein glycosylation (HP:0012346) | 1.92318227 |
| 93 | Abnormal glycosylation (HP:0012345) | 1.92318227 |
| 94 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92318227 |
| 95 | Progressive neurologic deterioration (HP:0002344) | 1.89711818 |
| 96 | Hyperaldosteronism (HP:0000859) | 1.88432172 |
| 97 | Type I transferrin isoform profile (HP:0003642) | 1.84853189 |
| 98 | Abnormality of T cell physiology (HP:0011840) | 1.84741871 |
| 99 | Abnormality of the thoracic spine (HP:0100711) | 1.82967821 |
| 100 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.80354123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 6.98714560 |
| 2 | ERN1 | 5.00662778 |
| 3 | EIF2AK3 | 4.45105662 |
| 4 | ARAF | 3.28978431 |
| 5 | TAOK2 | 3.20278937 |
| 6 | KSR2 | 3.09542835 |
| 7 | IRAK3 | 2.91549761 |
| 8 | BRAF | 2.76905611 |
| 9 | MAP3K9 | 2.62684870 |
| 10 | NME2 | 2.53909254 |
| 11 | ITK | 2.47822891 |
| 12 | TESK2 | 2.40224707 |
| 13 | MAP3K13 | 2.35889551 |
| 14 | CDK19 | 2.19908280 |
| 15 | TAF1 | 1.94844240 |
| 16 | EEF2K | 1.84180573 |
| 17 | SCYL2 | 1.74983363 |
| 18 | MAPK7 | 1.65400540 |
| 19 | TYK2 | 1.64019826 |
| 20 | LRRK2 | 1.50826622 |
| 21 | MAP3K1 | 1.42192857 |
| 22 | MAP3K10 | 1.37442481 |
| 23 | MAP4K1 | 1.30938402 |
| 24 | KSR1 | 1.29383914 |
| 25 | CDK3 | 1.27620505 |
| 26 | RAF1 | 1.27306332 |
| 27 | TBK1 | 1.27210744 |
| 28 | GRK6 | 1.23870735 |
| 29 | MAP3K14 | 1.21876503 |
| 30 | MAP3K8 | 1.09663793 |
| 31 | IRAK4 | 1.08822229 |
| 32 | PDPK1 | 1.00092359 |
| 33 | MOS | 0.99276482 |
| 34 | IRAK2 | 0.92789122 |
| 35 | JAK1 | 0.87934187 |
| 36 | STK16 | 0.86428713 |
| 37 | MARK3 | 0.86180696 |
| 38 | FGFR4 | 0.84087535 |
| 39 | PDK1 | 0.83033346 |
| 40 | IRAK1 | 0.80617636 |
| 41 | MAP2K2 | 0.77506530 |
| 42 | MAPK12 | 0.77153703 |
| 43 | CSF1R | 0.73978179 |
| 44 | AKT2 | 0.72408929 |
| 45 | MAP3K2 | 0.71542614 |
| 46 | JAK2 | 0.69348110 |
| 47 | STK10 | 0.68184435 |
| 48 | MST4 | 0.67914846 |
| 49 | BRSK1 | 0.67238499 |
| 50 | SIK1 | 0.67093236 |
| 51 | IKBKE | 0.65833883 |
| 52 | ICK | 0.61106945 |
| 53 | FGFR3 | 0.55015736 |
| 54 | DYRK1B | 0.51373110 |
| 55 | TTK | 0.50873916 |
| 56 | MST1R | 0.50537290 |
| 57 | IKBKB | 0.50078656 |
| 58 | JAK3 | 0.47534589 |
| 59 | TAOK3 | 0.46547315 |
| 60 | CDK11A | 0.44532817 |
| 61 | ALK | 0.43763247 |
| 62 | ZAP70 | 0.42272699 |
| 63 | CDK8 | 0.41291943 |
| 64 | EIF2AK1 | 0.37854388 |
| 65 | BLK | 0.37753231 |
| 66 | MARK2 | 0.37276980 |
| 67 | PAK1 | 0.37136664 |
| 68 | CDK15 | 0.36999496 |
| 69 | RPS6KB1 | 0.35463931 |
| 70 | SIK3 | 0.35179163 |
| 71 | PRKCI | 0.33638395 |
| 72 | CDK14 | 0.33536520 |
| 73 | CSNK2A1 | 0.33295099 |
| 74 | NEK1 | 0.32791452 |
| 75 | SRPK1 | 0.32717360 |
| 76 | CDK18 | 0.32069829 |
| 77 | LMTK2 | 0.31217926 |
| 78 | NME1 | 0.30512088 |
| 79 | FES | 0.27843740 |
| 80 | PIM1 | 0.26627112 |
| 81 | MAP3K3 | 0.24762446 |
| 82 | HCK | 0.24339354 |
| 83 | MAP3K11 | 0.23638348 |
| 84 | PRKG2 | 0.22252374 |
| 85 | OXSR1 | 0.19876158 |
| 86 | PDK2 | 0.19694908 |
| 87 | MAP3K5 | 0.19142897 |
| 88 | ACVR1B | 0.18921653 |
| 89 | EPHA3 | 0.18784875 |
| 90 | LCK | 0.18658590 |
| 91 | PRKD2 | 0.17712968 |
| 92 | MAPKAPK2 | 0.17560562 |
| 93 | SYK | 0.17357285 |
| 94 | MAP2K1 | 0.16875510 |
| 95 | CDK7 | 0.15835910 |
| 96 | MAP2K3 | 0.15700168 |
| 97 | DAPK2 | 0.15313430 |
| 98 | MELK | 0.13757435 |
| 99 | CHEK1 | 0.13715916 |
| 100 | PRKCQ | 0.13666955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.98636473 |
| 2 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 4.52963211 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.23099036 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.77876019 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.72583145 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58437673 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.37479446 |
| 8 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 2.27690844 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.12135835 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.10822989 |
| 11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.10063958 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.04023586 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 2.03871085 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.00042752 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.99127918 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.96425714 |
| 17 | Bladder cancer_Homo sapiens_hsa05219 | 1.86520991 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.83622435 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81581370 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.75813829 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.57633958 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.56074916 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51517471 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.41747154 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.38433416 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.37118800 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.37117538 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33848565 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32189019 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27159518 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18900790 |
| 32 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.18032557 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12434207 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09566918 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.07411808 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03528457 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 0.99756104 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 0.99070293 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 0.97301316 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96945743 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95989181 |
| 42 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.92544131 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89890544 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 0.89149948 |
| 45 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88119143 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87352288 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82718706 |
| 48 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82318815 |
| 49 | Protein export_Homo sapiens_hsa03060 | 0.77928339 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74101014 |
| 51 | Prostate cancer_Homo sapiens_hsa05215 | 0.72476537 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.71469970 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68702849 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68337263 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.66311549 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66113677 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.64954658 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63209216 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62652887 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62594602 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.62421872 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62329288 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61811209 |
| 64 | Base excision repair_Homo sapiens_hsa03410 | 0.61286808 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58658640 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.58118150 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57497261 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54613632 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54148423 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53737031 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53036996 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50949524 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50728423 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49882531 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49768034 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49640080 |
| 77 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.49427416 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49271788 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47485022 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46917389 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46331106 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44107862 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43330765 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42519631 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42491378 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38521791 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36449405 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36333427 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35921673 |
| 90 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35548626 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33318248 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.32946759 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32327212 |
| 94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31398414 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31164276 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30518999 |
| 97 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.28227928 |
| 98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27954404 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.27926855 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27706266 |

